What Next for Cancer Treatment and the NHS? | IPT
Chair: Nic Dakin MP, Chair of Cancer APPG
Speaker: Faisal Mehmud, UK/Ireland Country Medical Director, Bristol Myers Squibb
Speaker: Professor Nasir Rajpoot, Professor of Computational Pathology, Warwick University
Breakfast Meeting

Date:

Wednesday 09 October 2019

Venue:

House of Commons

Start Time:

08:30

End Time:

09:30

Almost one in two people will be diagnosed with cancer at some point in their life. The NHS Long-Term Plan aims to improve cancer care in the UK by providing all patients with a definitive diagnosis within 28 days by 2020 and rolling out new Rapid Diagnostic and Assessment centres. Further plans include creating simpler, standardised clinical trial processes and fast-tracking new products into the NHS. As understanding of cancer leads to the development of more targeted and sophisticated treatments, such as the Nobel Prize for Medicine 2018 winning discovery of cancer immunotherapy, how can Government, industry and the third sector work together to ensure that patients in the UK are able to benefit from new breakthroughs?

This breakfast meeting will:

  • Consider how the UK compares to other nations in cancer survival
  • Explore the potential impact of cancer immunotherapy for patients and the NHS
  • Discuss the impact of new technologies in allowing for early diagnosis and personalised treatments, including the workforce skill required for research and treatment.